Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study

BACKGROUND: Liver transplant (LT) recipients were considered a vulnerable population during the coronavirus disease 2019 (COVID-19) pandemic. The clinical efficacy of the COVID-19 vaccine is unknown in immunocompromised patients. The purpose of this study was to provide evidence of antibody response...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Young Ju, Kim, Jongman, Kang, Eun-Suk, Rhu, Jinsoo, Choi, Gyu-Seong, Joh, Jae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125795/
https://www.ncbi.nlm.nih.gov/pubmed/37096307
http://dx.doi.org/10.3346/jkms.2023.38.e121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125795/
https://www.ncbi.nlm.nih.gov/pubmed/37096307
http://dx.doi.org/10.3346/jkms.2023.38.e121

Ejemplares similares